Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice (Q48222795)

9 February 2018

title

Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice (English)

1 reference

9 February 2018

author

Etienne Lefai

13

1 reference

9 February 2018

Jérôme Ruzzin

15

1 reference

9 February 2018

Jennifer Rieusset

Jennifer Rieusset

12

0 references

Hubert Vidal

Hubert Vidal

14

0 references

Nadia Bendridi

7

Nadia Bendridi

1 reference

9 February 2018

Emmanuelle Meugnier

2

Emmanuelle Meugnier

1 reference

9 February 2018

Sandra Pesenti

8

Sandra Pesenti

1 reference

9 February 2018

Christine M. Durand

6

Christine Durand

1 reference

9 February 2018

Bérengère Benoit

1

Bérengère Benoit

1 reference

9 February 2018

Stéphanie Chanon

4

Stéphanie Chanon

1 reference

9 February 2018

author name string

Martina Castelli

3

1 reference

9 February 2018

Aurélie Vieille-Marchiset

5

1 reference

9 February 2018

Pierre-Axel Monternier

9

1 reference

9 February 2018

Anne-Cécile Durieux

10

1 reference

9 February 2018

Damien Freyssenet

11

1 reference

9 February 2018

language of work or name

English

0 references

publication date

26 June 2017

1 reference

9 February 2018

published in

Nature Medicine

1 reference

9 February 2018

volume

23

1 reference

9 February 2018

issue

8

1 reference

9 February 2018

page(s)

990-996

1 reference

9 February 2018

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

cites work

1 reference

Liver-specific activities of FGF19 require Klotho beta

21 January 2018

1 reference

Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.

21 January 2018

1 reference

The Fibroblast Growth Factor signaling pathway

21 January 2018

1 reference

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

21 January 2018

1 reference

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue

21 January 2018

1 reference

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

21 January 2018

1 reference

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

21 January 2018

1 reference

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

21 January 2018

1 reference

FGF19 action in the brain induces insulin-independent glucose lowering

21 January 2018

1 reference

Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice

21 January 2018

1 reference

Muscle as a "mediator" of systemic metabolism

21 January 2018

1 reference

FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway

21 January 2018

1 reference

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

21 January 2018

1 reference

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

21 January 2018

1 reference

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

21 January 2018

1 reference

Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle.

21 January 2018

1 reference

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

21 January 2018

1 reference

Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy.

21 January 2018

1 reference

A simplified immunohistochemical classification of skeletal muscle fibres in mouse

21 January 2018

1 reference

Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening

21 January 2018

1 reference

Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.

21 January 2018

1 reference

βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism

21 January 2018

1 reference

Gene targeting restricted to mouse striated muscle lineage

21 January 2018

1 reference

Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells.

21 January 2018

1 reference

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors

21 January 2018

1 reference

TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism

21 January 2018

1 reference

Persistent organic pollutant exposure leads to insulin resistance syndrome

21 January 2018

1 reference

FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction

21 January 2018

1 reference

Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM.4363

1 reference

9 February 2018

release_lerm6jnylfgdpnrqwc23fohcai

Fatcat ID

0 references

1 reference

9 February 2018